Welcome to LookChem.com Sign In|Join Free
  • or
MSX-122 is a CXCR4 inhibitor with potential antineoplastic and antiviral activities.

897657-95-3

Post Buying Request

897657-95-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

897657-95-3 Usage

Uses

Used in Antineoplastic Applications:
MSX-122 is used as an antineoplastic agent for its potential to inhibit the recruitment of inflammatory cells to inflammation sites, thereby reducing tumor growth and progression.
Used in Antiviral Applications:
MSX-122 is used as an antiviral agent for its potential to inhibit the CXCR4 receptor, which may play a role in viral entry and replication.

Check Digit Verification of cas no

The CAS Registry Mumber 897657-95-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,7,6,5 and 7 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 897657-95:
(8*8)+(7*9)+(6*7)+(5*6)+(4*5)+(3*7)+(2*9)+(1*5)=263
263 % 10 = 3
So 897657-95-3 is a valid CAS Registry Number.

897657-95-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name N-[[4-[(pyrimidin-2-ylamino)methyl]phenyl]methyl]pyrimidin-2-amine

1.2 Other means of identification

Product number -
Other names UNII-69D634Q702

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:897657-95-3 SDS

897657-95-3Upstream product

897657-95-3Downstream Products

897657-95-3Relevant academic research and scientific papers

CXCR4 ANTAGONISTS FOR THE TREATMENT OF HIV INFECTION

-

Page/Page column 65, (2008/06/13)

The invention provides compounds, pharmaceutical compositions and methods of use of certain compounds that are antagonists of the chemokine CXCR4 receptor, and in particular to inhibit viral entry of certain viruses. Certain compounds in particular can reduce entry of immunodeficiency virus (HIV) into a cell while not reducing the capacity of stem cells to proliferate, and therefore can be useful for long term treatment regimes. The compounds are useful in particular in the treatment or prevention of HIV infections.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 897657-95-3